ES8800680A1 - Un procedimiento para la preparacion de nuevos acidos cefalosporanicos y sus esteres. - Google Patents

Un procedimiento para la preparacion de nuevos acidos cefalosporanicos y sus esteres.

Info

Publication number
ES8800680A1
ES8800680A1 ES556465A ES556465A ES8800680A1 ES 8800680 A1 ES8800680 A1 ES 8800680A1 ES 556465 A ES556465 A ES 556465A ES 556465 A ES556465 A ES 556465A ES 8800680 A1 ES8800680 A1 ES 8800680A1
Authority
ES
Spain
Prior art keywords
esters
hydrogen
acids
ylcephalosporanic
aminothiazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES556465A
Other languages
English (en)
Other versions
ES556465A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ES556465A0 publication Critical patent/ES556465A0/es
Publication of ES8800680A1 publication Critical patent/ES8800680A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/227-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE ACIDOS CEFALOSPORINICOS Y SUS ESTERES, DE FORMULA GENERAL (I). CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA GENERAL (II), EN LA QUE R1K, ES UN GRUPO BLOQUEANTE CONVENCIONAL UTILIZADO EN LA QUIMICA DE LAS CEFALOSPORINAS PARA LOS GRUPOS AMINO; R2A ES UN GRUPO BLOQUEANTE UTILIZADO EN LA QUIMICA DE LAS CEFALOSPORINAS PARA LOS GRUPOS HIDROXI; Y R4K ES UN GRUPO BLOQUEANTE UTILIZADO EN LA QUIMICA DE LAS CEFALOSPORINAS PARA LOS GRUPOS CARBOXILO, CON UN ALDEHIDO DE FORMULA: R3CH2CHO, EN LA QUE R3 ES HIDROGENO, ALQUILO INFERIOR O ALCOXI INFERIOR, EN UN MEDIO DE REACCION ORGANICO INERTE TAL COMO DICLOROMETANO. DE APLICACION COMO ANTIBIOTICOS EN EL TRATAMIENTO Y PREVENCION DE LAS ENFE RMEDADES INFECCIOSAS DE LSO MAMIFEROS.
ES556465A 1985-06-24 1986-06-23 Un procedimiento para la preparacion de nuevos acidos cefalosporanicos y sus esteres. Expired ES8800680A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/748,359 US4708955A (en) 1985-06-24 1985-06-24 3-(substituted)propenyl-7-aminothiazol-ylcephalosporanic acids and esters thereof

Publications (2)

Publication Number Publication Date
ES556465A0 ES556465A0 (es) 1987-11-01
ES8800680A1 true ES8800680A1 (es) 1987-11-01

Family

ID=25009129

Family Applications (1)

Application Number Title Priority Date Filing Date
ES556465A Expired ES8800680A1 (es) 1985-06-24 1986-06-23 Un procedimiento para la preparacion de nuevos acidos cefalosporanicos y sus esteres.

Country Status (36)

Country Link
US (1) US4708955A (es)
JP (1) JPS62491A (es)
KR (1) KR930007416B1 (es)
AR (1) AR244233A1 (es)
AT (1) AT390956B (es)
AU (1) AU593557B2 (es)
BE (1) BE904983A (es)
CA (1) CA1279868C (es)
CS (1) CS258142B2 (es)
CY (1) CY1618A (es)
DD (1) DD246112A5 (es)
DE (1) DE3620995A1 (es)
DK (1) DK295386A (es)
EG (1) EG17868A (es)
ES (1) ES8800680A1 (es)
FI (1) FI85487C (es)
FR (1) FR2583757B1 (es)
GB (1) GB2178032B (es)
GR (1) GR861611B (es)
HK (1) HK106091A (es)
HU (1) HU199484B (es)
IE (1) IE59123B1 (es)
IL (1) IL79181A0 (es)
IT (1) IT1221767B (es)
LU (1) LU86488A1 (es)
MY (1) MY102073A (es)
NL (1) NL8601645A (es)
NZ (1) NZ216614A (es)
OA (1) OA08349A (es)
PH (2) PH21206A (es)
PT (1) PT82836B (es)
SE (1) SE500218C2 (es)
SG (1) SG91691G (es)
SU (1) SU1428204A3 (es)
YU (1) YU45787B (es)
ZA (1) ZA864297B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874856A (en) * 1985-06-24 1989-10-17 Bristol-Myers Company 3-(substituted)propenyl-7-(aminothiazolylacetamido) ceph-3-em-4-carboxylic acids and esters thereof
GB8519606D0 (en) * 1985-08-05 1985-09-11 Fujisawa Pharmaceutical Co 3 7-d substituted-3-cephem compounds
US4870168A (en) * 1987-02-26 1989-09-26 Bristol-Myers Company 3-Unsaturated alkyl cephems from 3-triflyl cephems
FR2622585B1 (fr) * 1987-11-03 1991-04-19 Roussel Uclaf Nouvelles cephalosporines comportant en position 3 un radical vinyle substitue, leur procede de preparation, leur application comme medicaments, les compositions les renfermant et les nouveaux intermediaires obtenus
US4935508A (en) * 1988-08-23 1990-06-19 Bristol-Myers Company Process for cephem prodrug esters
US5143911A (en) * 1990-08-23 1992-09-01 Bristol-Myers Squibb Company Antibiotic c-3 di-hydroxyphenyl substituted cephalosporin compounds, compositions and method of use thereof
JP2825655B2 (ja) * 1992-02-05 1998-11-18 バイオケミ・ゲゼルシヤフト・エム・ベー・ハー 3−セフェム−4−カルボン酸誘導体の精製方法
JPH07173168A (ja) * 1993-07-14 1995-07-11 Sumitomo Chem Co Ltd セフェム系化合物、その製法、およびそれのセフェム系抗生物質製造への利用
KR100408430B1 (ko) * 2001-04-18 2003-12-06 한미약품 주식회사 3-(z)-프로페닐 세펨 화합물의 선택적인 제조 방법
WO2005042543A1 (en) * 2003-10-30 2005-05-12 Cj Corporation Processes for the preparation of cephem derivatives

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3917778A (en) * 1968-04-13 1975-11-04 Tdk Electronics Co Ltd Method for slip casting soft ferromagnetic ferrites
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
US4065620A (en) * 1971-06-14 1977-12-27 Eli Lilly And Company 3-(Substituted) vinyl cephalosporins
FR2345153A1 (fr) * 1976-03-25 1977-10-21 Roussel Uclaf Nouvelles alcoyloximes derivees de l'acide 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
US4464369A (en) * 1977-03-14 1984-08-07 Fujisawa Pharmaceutical Co., Ltd. 7-Acylamino-3-cephem-4-carboxylic acid derivatives and pharmaceutical compositions
GB2051788B (en) * 1979-05-23 1984-01-18 Rhone Poulenc Ind 3 - thiovinyl - cephalosporins their preparation and compositions containing them
FR2457296A1 (fr) * 1979-05-23 1980-12-19 Rhone Poulenc Ind Nouveaux derives de vinyl-3 cephalosporines et leur preparation
FR2457297A1 (fr) * 1979-05-23 1980-12-19 Rhone Poulenc Ind Nouvelles vinyl-3 cephalosporines, et leur preparation
US4409214A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical, Co., Ltd. 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
FR2494275A2 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouveaux derives de vinyl-3 cephalosporines et leur preparation
FR2494276A2 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouvelles vinyl-3 cephalosporines, et leur preparation
FR2494280A1 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouveaux derives de la cephalosporine et leur preparation
IE53429B1 (en) * 1981-08-03 1988-11-09 Fujisawa Pharmaceutical Co New cephem compounds and processes for preparation thereof
DK162718C (da) * 1982-09-30 1992-05-11 Fujisawa Pharmaceutical Co Analogifremgangsmaade til fremstilling af 7-substitueret-3-vinyl-3-cephemforbindelser
GB8323034D0 (en) * 1983-08-26 1983-09-28 Fujisawo Pharmaceutical Co Ltd 7-substituted-3-vinyl-3-cephem compounds
US4520022A (en) * 1983-01-28 1985-05-28 Bristol-Myers Company Substituted vinyl cephalosporins
US4486586A (en) * 1983-02-10 1984-12-04 Bristol-Myers Company Cephalosporin derivatives
CA1276929C (en) * 1984-04-09 1990-11-27 Masahisa Oka Cephalosporin antibacterial agents
GB8411954D0 (en) * 1984-05-10 1984-06-13 Glaxo Group Ltd Cephalosporin antibiotics
FR2580652B1 (fr) * 1985-04-22 1989-01-06 Bristol Myers Co Acide 7-amino-3-propenylcephalosporanique et ses esters

Also Published As

Publication number Publication date
NZ216614A (en) 1990-03-27
HUT43074A (en) 1987-09-28
GB2178032A (en) 1987-02-04
US4708955A (en) 1987-11-24
SE8602780L (sv) 1986-12-25
CY1618A (en) 1992-07-10
GB2178032B (en) 1989-04-26
FI862642A (fi) 1986-12-25
IT8620894A0 (it) 1986-06-24
AU593557B2 (en) 1990-02-15
YU45787B (sh) 1992-07-20
PH21206A (en) 1987-08-19
PT82836A (en) 1986-07-01
ATA171986A (de) 1990-01-15
NL8601645A (nl) 1987-01-16
PH21879A (en) 1988-03-25
IT1221767B (it) 1990-07-12
DK295386D0 (da) 1986-06-23
GR861611B (en) 1986-10-30
AR244233A1 (es) 1993-10-29
FI85487C (fi) 1992-04-27
IL79181A0 (en) 1986-09-30
CA1279868C (en) 1991-02-05
FI85487B (fi) 1992-01-15
CS258142B2 (en) 1988-07-15
PT82836B (pt) 1989-01-17
OA08349A (fr) 1988-02-29
SE500218C2 (sv) 1994-05-09
YU110086A (en) 1987-10-31
LU86488A1 (fr) 1987-01-13
FR2583757B1 (fr) 1989-01-13
ES556465A0 (es) 1987-11-01
SG91691G (en) 1991-12-13
JPS62491A (ja) 1987-01-06
DD246112A5 (de) 1987-05-27
AU5882186A (en) 1987-01-08
HU199484B (en) 1990-02-28
SU1428204A3 (ru) 1988-09-30
AT390956B (de) 1990-07-25
DE3620995A1 (de) 1987-01-08
MY102073A (en) 1992-03-31
IE59123B1 (en) 1994-01-12
FI862642A0 (fi) 1986-06-19
ZA864297B (en) 1987-02-25
EG17868A (en) 1994-01-30
FR2583757A1 (fr) 1986-12-26
BE904983A (fr) 1986-12-23
HK106091A (en) 1992-01-03
SE8602780D0 (sv) 1986-06-23
IE861670L (en) 1986-12-24
CS462486A2 (en) 1987-11-12
GB8615253D0 (en) 1986-07-30
KR870000342A (ko) 1987-02-18
DK295386A (da) 1986-12-25
KR930007416B1 (ko) 1993-08-10

Similar Documents

Publication Publication Date Title
IE850293L (en) Penicillin compounds
HUT67691A (en) 7-(substituted)-8-(substituted)-9-[(substituted-glycyl)amido]6-demethyl-6-deoxytetracyclines, pharmaceutical compositions containing them and process to prepare them
DE3168572D1 (en) Cephalosporin derivatives, process for their preparation and antibiotic compositions containing them
ES8303386A1 (es) "un procedimiento para preparar acidos y esteres aminociclopentano-alquenoicos".
ES8800680A1 (es) Un procedimiento para la preparacion de nuevos acidos cefalosporanicos y sus esteres.
NZ308518A (en) Antibacterial cephalosporins
AU6889294A (en) Novel intermediates useful in the preparation of heteroaroyl derivatives of monocyclic beta-lactam antibiotics
IE782502L (en) Cephalosporins
SE7713901L (sv) Tiooximcefalosporin- och penicillin-derivat
EP0304036A3 (en) 3-(substituted)propenyl-7-(aminothiazolylacetamido)ceph-3-em-4-carboxylic acids and esters thereof
GB1501711A (en) Hydroxy-substituted cephalosporins
GR3023757T3 (en) Cyclic benzylamino, benzylamido and benzylimido derivatives as antipsychotic agents.
ES459945A1 (es) Un procedimiento para la preparacion de nuevos derivados de cefalosporina.
AU555185B2 (en) Cephalosporin antibiotics
ES8703470A1 (es) Un procedimiento para la preparacion de una octahidroindo- lizina
ES8306746A1 (es) Un procedimiento para la preparacion de 1h- o 2h-tetrazol-5-tiol
EG16163A (en) Antibiotic a 51568 factor a and b
ES8702917A1 (es) Un procedimiento para preparar compuestos de cefalosporina
EP0574271A3 (es)
ES423024A1 (es) Procedimiento para la preparacion de derivados de acidos penicilanico y cefalosporanico.
EP0377127A3 (de) Verwendung von Myricetin-3-0-beta-D-glucuronid als Arzneimittel
JPS6422850A (en) 2-alkoxypropionamide derivative and its preparation
AT383809B (de) Verfahren zur herstellung von cephalosporinantibiotika
JPS5212191A (en) Antibacterial compositions

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519